Cargando…

Non-alcoholic fatty liver disease and lipotoxicity

Non-alcoholic fatty liver disease (NAFLD) has become the most common liver pathology worldwide due to the rising prevalence of obesity. This term includes changes from simple steatosis to steatohepatitis and fibrosis. It was previously thought to be a hepatic manifestation of metabolic syndrome, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasilewska, Natalia, Lebensztejn, Dariusz Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122097/
https://www.ncbi.nlm.nih.gov/pubmed/34027109
http://dx.doi.org/10.5114/ceh.2021.104441
_version_ 1783692514675392512
author Wasilewska, Natalia
Lebensztejn, Dariusz Marek
author_facet Wasilewska, Natalia
Lebensztejn, Dariusz Marek
author_sort Wasilewska, Natalia
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) has become the most common liver pathology worldwide due to the rising prevalence of obesity. This term includes changes from simple steatosis to steatohepatitis and fibrosis. It was previously thought to be a hepatic manifestation of metabolic syndrome, but recent literature describes this relation as much more complex and bi-directional. Development of NAFLD is associated with other metabolic syndrome components but it can also exacerbate insulin resistance and increase cardiovascular risk. Recently a lot of attention is brought to the role of lipids and lipotoxicity in pathogenesis and progression of non-alcoholic fatty disease. It seems that some lipid classes can be protective against liver injury while others are harmful in excessive amounts. This study presents an overview of the main lipids involved in the pathogenesis of non-alcoholic fatty liver disease and summarizes their association with lipotoxicity, insulin resistance, oxidative stress and other processes responsible for its progression.
format Online
Article
Text
id pubmed-8122097
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-81220972021-05-21 Non-alcoholic fatty liver disease and lipotoxicity Wasilewska, Natalia Lebensztejn, Dariusz Marek Clin Exp Hepatol Review Paper Non-alcoholic fatty liver disease (NAFLD) has become the most common liver pathology worldwide due to the rising prevalence of obesity. This term includes changes from simple steatosis to steatohepatitis and fibrosis. It was previously thought to be a hepatic manifestation of metabolic syndrome, but recent literature describes this relation as much more complex and bi-directional. Development of NAFLD is associated with other metabolic syndrome components but it can also exacerbate insulin resistance and increase cardiovascular risk. Recently a lot of attention is brought to the role of lipids and lipotoxicity in pathogenesis and progression of non-alcoholic fatty disease. It seems that some lipid classes can be protective against liver injury while others are harmful in excessive amounts. This study presents an overview of the main lipids involved in the pathogenesis of non-alcoholic fatty liver disease and summarizes their association with lipotoxicity, insulin resistance, oxidative stress and other processes responsible for its progression. Termedia Publishing House 2021-03-25 2021-03 /pmc/articles/PMC8122097/ /pubmed/34027109 http://dx.doi.org/10.5114/ceh.2021.104441 Text en Copyright © 2021 Clinical and Experimental Hepatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Review Paper
Wasilewska, Natalia
Lebensztejn, Dariusz Marek
Non-alcoholic fatty liver disease and lipotoxicity
title Non-alcoholic fatty liver disease and lipotoxicity
title_full Non-alcoholic fatty liver disease and lipotoxicity
title_fullStr Non-alcoholic fatty liver disease and lipotoxicity
title_full_unstemmed Non-alcoholic fatty liver disease and lipotoxicity
title_short Non-alcoholic fatty liver disease and lipotoxicity
title_sort non-alcoholic fatty liver disease and lipotoxicity
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122097/
https://www.ncbi.nlm.nih.gov/pubmed/34027109
http://dx.doi.org/10.5114/ceh.2021.104441
work_keys_str_mv AT wasilewskanatalia nonalcoholicfattyliverdiseaseandlipotoxicity
AT lebensztejndariuszmarek nonalcoholicfattyliverdiseaseandlipotoxicity